Commercial Study Will Measure Impact of Increasing Access and
Affordability of Aesthetic Procedures
IRVINE, Calif.–(BUSINESS WIRE)–PatientFi, LLC, a leading financial technology company that partners
with medical practices to offer patients accessible financing plans for
elective procedures, is pleased to announce its partnership with
Allergan plc on a year-long market research study to examine the impact
of financing plans on patients’ accessibility to aesthetic procedures.
PatientFi has designed a new patient financing program that aligns
practice staff to help more patients finance procedures such as breast
augmentation, mommy makeovers, and surgical facial rejuvenation. As
such, PatientFi is uniquely situated to study patient decision-making
factors, including perceived value and affordability.
“PatientFi is excited to partner with Allergan, a world leader in
medical aesthetics, and together help gain an understanding of the
growth potential of this market by identifying the key financial
barriers patients face when considering aesthetic procedures,” says Dr.
Louis Bucky, Chairman, PatientFi, LLC. “The rate of innovation in
patient financing has not kept pace with the clinical developments of
medical aesthetics. We look forward to the results of this market
research study.”
Founded by healthcare industry veterans Scott Jorgensen and Todd Watts,
PatientFi is solving a number of problems with the patient financing
industry today by reducing expensive merchant processing fees and
offering patient-friendly financing options delivered via a proprietary,
instantaneous credit application and decision process that provides
personalized payment plans tailored to each aesthetic patient’s profile
and budget.
Allergan commissioned this patient study through PatientFi’s platform
because of its innovative approach to increasing access and
affordability for patients across the broadest offering of aesthetic
procedures. Allergan and PatientFi plan to present their findings in
Spring 2020.
About PatientFi®
Based in Irvine, California, PatientFi, LLC is a leading financial
technology company that partners with medical practices to offer
patients accessible financing plans for elective procedures. The
PatientFi platform increases patients’ access to and affordability of
aesthetic services and procedures by delivering high approval rates via
monthly payment plan packages with instant approvals. With PatientFi,
medical practices can now better target and qualify patient leads prior
to consultation, increasing the practice’s overall efficiency, patient
acceptance rates and profitability.
About Allergan plc
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global
pharmaceutical leader focused on developing, manufacturing and
commercializing branded pharmaceutical, device, biologic, surgical and
regenerative medicine products for patients around the world. Allergan
markets a portfolio of leading brands and best-in-class products
primarily focused on four key therapeutic areas including medical
aesthetics, eye care, central nervous system and gastroenterology. As
part of its approach to delivering innovation for better patient care,
Allergan has built one of the broadest pharmaceutical and device
research and development pipelines in the industry. With colleagues and
commercial operations located in approximately 100 countries, Allergan
is committed to working with physicians, healthcare providers and
patients to deliver innovative and meaningful treatments that help
people around the world live longer, healthier lives every day.
Contacts
PatientFi Media Contact:
Shannon Johnson
(818) 721-6801
Email:
shannon@patientfi.com
Allergan Media Contact:
Amy Rose
(862) 289-3072
Email:
rose_amy@allergan.com
Lisa Brown
(862) 261-7320
Email: brown_lisa@allergan.com